Donald J Santel
CIK 1293630 · CEO & President · last filed 2024-06-07
Donald J Santel is a CEO & President who has filed 17 SEC Form 4 insider transactions across 6 companies since 2007. The most recent filing, for AVTE, was dated Jun 7, 2024. Current disclosed insider exposure totals $542 across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$542
6
17
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Jade Biosciences, Inc. (AVTE) Delisted | Director | — | $93.80 | — | $0 | 4 | 2024-06-07 |
| Oyster Point Pharma, Inc. (OYST) Delisted | Director | 0 | $11.17 | $0 | $0 | 3 | 2023-01-04 |
| SRZNW | 30,000 | $0.02 | $542 | $0 | 1 | 2021-08-13 | |
| HYPERION THERAPEUTICS INC (HPTX) Delisted | CEO & President | 0 | — | — | $0 | 6 | 2015-05-08 |
| Anthera Pharmaceuticals Inc (ANTH) Delisted | Director | — | — | — | $0 | 2 | 2011-07-05 |
| COTHERIX INC (CTRX) Delisted | Chief Executive Officer | 0 | — | — | $0 | 1 | 2007-01-10 |
Recent Filings
17 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-07 | Jade Biosciences, Inc. (AVTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2024-01-04 | Jade Biosciences, Inc. (AVTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-06-08 | Jade Biosciences, Inc. (AVTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-23 | Jade Biosciences, Inc. (AVTE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-01-04 | Oyster Point Pharma, Inc. (OYST) Delisted | Mixed | −13,687 | $0 | EDGAR |
| 2022-06-08 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | +3,573 | $0 | EDGAR |
| 2021-08-13 | SRZNW | Mixed | +30,000 | $0 | EDGAR |
| 2021-08-03 | Oyster Point Pharma, Inc. (OYST) Delisted | Grant (A) | +10,114 | $0 | EDGAR |
| 2015-05-08 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Mixed | −358,402 | -$16.49M | EDGAR |
| 2015-05-05 | HYPERION THERAPEUTICS INC (HPTX) Delisted | Exer (M) | +292,057 | $675.6K | EDGAR |